Annexon Inc reports results for the quarter ended June 30 - Earnings Summary

Annexon

14/08/2025 21:31

Annexon Inc ANNX.OQ reported a quarterly adjusted loss of 34 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -23 cents.  The mean expectation of eight analysts for the quarter was for a loss of 37 cents per share. Wall Street expected results to range from -38 cents to -35 cents per share.

Reported revenue was zero​; analysts expected zero.

Annexon Inc's reported EPS for the quarter was a loss of 34 cents​.

The company reported a quarterly loss of $51.01 million.

Annexon Inc shares had risen by 8.3% this quarter and lost 49.3% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 5.5% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Annexon Inc is $11.00, about 76.4% above its last closing price of $2.60

This summary was machine generated from LSEG data August 14 at 08:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
-0.37
-0.34
Beat
Mar. 31 2025
-0.30
-0.37
Missed
Dec. 31 2024
-0.27
-0.33
Missed
Sep. 30 2024
-0.26
-0.25
Beat